Review



prism v.6.0 program suite  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GraphPad Software Inc prism v.6.0 program suite
    Prism V.6.0 Program Suite, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+software/10__1007_slash_s10600___024___04518___w-120-10-9
    Average 90 stars, based on 1 article reviews
    prism v.6.0 program suite - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Activity Assay:

    Article Title: Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
    Article Snippet: Statistics were performed in the GraphPad Prism program suite (GraphPad Software, Inc., La Jolla, CA) and the Statistica program suite (StatSoft, Tulsa, OK).

    Article Title: Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
    Article Snippet: Statistics were carried out in the GraphPad Prism program suite (GraphPad Software, Inc.) and Statistica program suite (StatSoft).

    Software:

    Article Title: Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
    Article Snippet: Statistics were performed in the GraphPad Prism program suite (GraphPad Software, Inc., La Jolla, CA) and the Statistica program suite (StatSoft, Tulsa, OK).

    Article Title: Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
    Article Snippet: Statistics were carried out in the GraphPad Prism program suite (GraphPad Software, Inc.) and Statistica program suite (StatSoft).

    Western Blot:

    Article Title: Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
    Article Snippet: Statistics were performed in the GraphPad Prism program suite (GraphPad Software, Inc., La Jolla, CA) and the Statistica program suite (StatSoft, Tulsa, OK).

    Article Title: Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
    Article Snippet: Statistics were carried out in the GraphPad Prism program suite (GraphPad Software, Inc.) and Statistica program suite (StatSoft).

    In Vitro:

    Article Title: Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
    Article Snippet: Statistics were performed in the GraphPad Prism program suite (GraphPad Software, Inc., La Jolla, CA) and the Statistica program suite (StatSoft, Tulsa, OK).

    Article Title: Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
    Article Snippet: Statistics were carried out in the GraphPad Prism program suite (GraphPad Software, Inc.) and Statistica program suite (StatSoft).

    In Silico:

    Article Title: Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
    Article Snippet: Statistics were performed in the GraphPad Prism program suite (GraphPad Software, Inc., La Jolla, CA) and the Statistica program suite (StatSoft, Tulsa, OK).

    Article Title: Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
    Article Snippet: Statistics were carried out in the GraphPad Prism program suite (GraphPad Software, Inc.) and Statistica program suite (StatSoft).



    Similar Products

    prism v.6.0 program suite  (GraphPad Software Inc)
    90
    GraphPad Software Inc prism v.6.0 program suite
    Prism V.6.0 Program Suite, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+software/10__1007_slash_s10600___024___04518___w-120-10-9
    Average 90 stars, based on 1 article reviews
    prism v.6.0 program suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    prism program suite  (GraphPad Software Inc)
    90
    GraphPad Software Inc prism program suite
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Prism Program Suite, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+program+suite/pmc07907707-180-18-18
    Average 90 stars, based on 1 article reviews
    prism program suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    prism program suite version 8  (GraphPad Software Inc)
    90
    GraphPad Software Inc prism program suite version 8
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Prism Program Suite Version 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+software/pmc07907707-4-10-15
    Average 90 stars, based on 1 article reviews
    prism program suite version 8 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    software suite of the graphpad prism computer program  (GraphPad Software Inc)
    90
    GraphPad Software Inc software suite of the graphpad prism computer program
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Software Suite Of The Graphpad Prism Computer Program, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/computer+software+graphpad+prism/us10905679-324-15-15
    Average 90 stars, based on 1 article reviews
    software suite of the graphpad prism computer program - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    prism 6.07 suite programs  (GraphPad Software Inc)
    90
    GraphPad Software Inc prism 6.07 suite programs
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Prism 6.07 Suite Programs, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+software/pm27177841-118-11-10
    Average 90 stars, based on 1 article reviews
    prism 6.07 suite programs - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    nonlinear regression analysis program in the prism software suite version 6  (GraphPad Software Inc)
    90
    GraphPad Software Inc nonlinear regression analysis program in the prism software suite version 6
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Nonlinear Regression Analysis Program In The Prism Software Suite Version 6, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+software/pm26138469-82-13-23
    Average 90 stars, based on 1 article reviews
    nonlinear regression analysis program in the prism software suite version 6 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    prism, version 5.01, suite programs  (GraphPad Software Inc)
    90
    GraphPad Software Inc prism, version 5.01, suite programs
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Prism, Version 5.01, Suite Programs, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+version+5+00+windows/pmc04255739-234-22-21
    Average 90 stars, based on 1 article reviews
    prism, version 5.01, suite programs - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    nonlinear least-squares curve-fitting routine in the prism 4 suite of programs  (GraphPad Software Inc)
    90
    GraphPad Software Inc nonlinear least-squares curve-fitting routine in the prism 4 suite of programs
    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the <t>GraphPad</t> <t>Prism</t> <t>program</t> <t>suite.</t>
    Nonlinear Least Squares Curve Fitting Routine In The Prism 4 Suite Of Programs, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prism+program+suite/prism+curve+fitting+software/pmc03587353-103-29-30
    Average 90 stars, based on 1 article reviews
    nonlinear least-squares curve-fitting routine in the prism 4 suite of programs - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the GraphPad Prism program suite.

    Journal: Data in Brief

    Article Title: Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation

    doi: 10.1016/j.dib.2021.106858

    Figure Lengend Snippet: Potent flavonol analogs significantly inhibit c-Kit, CDK2, and mTOR kinase activities. Data from the determination of kinase inhibitory activity and IC 50 values for potent flavonol analogs and fisetin. IC 50 values (μM) calculated for potent inhibitors of: A) c-Kit, B) CDK2/Cyclin A, C) CDK2/Cyclin E and D) mTOR. Values are expressed as means ± SD of three independent assays, and all graphs were made using the GraphPad Prism program suite.

    Article Snippet: Values are expressed as means ± SD of three independent assays, and all graphs were made using the GraphPad Prism program suite.

    Techniques: Activity Assay

    Journal: Data in Brief

    Article Title: Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation

    doi: 10.1016/j.dib.2021.106858

    Figure Lengend Snippet:

    Article Snippet: Values are expressed as means ± SD of three independent assays, and all graphs were made using the GraphPad Prism program suite.

    Techniques: Software, Western Blot, In Vitro